Abstract:Abstract Objective The melanocortin 4 receptor (MC4R) is a G protein-coupled receptor that plays major roles in the central control of energy balance. Loss-of-function mutations of MC4R constitute the most common monogenic cause of early-onset extreme obesity in humans, whereas gain-of-function mutations appear to be protective. In particular, two relatively frequent alleles carrying the non-synonymous coding mutations V103I or I251L have been associated with lower risks of obesity and type-2 diabetes. Although V103I and I251L MC4Rs showed more efficient signaling in transfected cells, their specific effects in live animals remain unexplored. Here, we investigated whether the introduction of V103I and I251L mutations into the mouse MC4R leads to a lean phenotype and provides protection against an obesogenic diet. Methods Using CRISPR/Cas9, we generated two novel strains of mice carrying single nucleotide mutations into the mouse Mc4r which are identical to those present in V103I and I251L MCR4 human alleles, and studied their phenotypic outcomes in mice fed with normal chow or a high- fat diet. In particular, we measured body weight progression, food intake and adiposity. In addition, we analyzed glucose homeostasis through glucose and insulin tolerance tests. Results We found that homozygous V103I females displayed shorter longitudinal length and decreased abdominal white fat, whereas homozygous I251L females were also shorter and leaner due to decreased weight in all white fat pads examined. Homozygous Mc4r V103I/V103I and Mc4r I251L/I251L mice of both sexes showed improved glucose homeostasis when challenged in a glucose tolerance test, whereas Mc4r I251L/I251L females showed improved responses to insulin. Despite being leaner and metabolically more efficient, V103I and I251L mutants fed with a hypercaloric diet increased their fasting glucose levels and adiposity similar to their wild-type littermates. Conclusions Altogether, our results demonstrate that mice carrying V103I and I251L MC4R mutations displayed gain-of-function phenotypes that were more evident in females. However, hypermorphic MC4R mutants were as susceptible as their control littermates to the obesogenic and diabetogenic effects elicited by a long-term hypercaloric diet, highlighting the importance of healthy feeding habits even under favorable genetic conditions. Highlights Identical single nucleotide substitutions to gain-of-function mutations of the human MC4R were introduced into the genome of inbred mice using CRISPR/Cas9 technology. Homozygous female carriers of V103I Mc4r alleles are shorter and display reduced adiposity, together with improved glucose homeostasis in both sexes. Homozygous females carrying the I251L mutation in the mouse MC4R also display shorter longitudinal length, decreased weight in all abdominal white fat pads and improved glucose clearance and insulin response. Gain-of-function mutations V103I and I251L of MC4R do not protect against the diabetogenic and adipogenic effects of a high-fat diet.

Human ACVR1C missense variants that correlate with altered body fat distribution produce metabolic alterations of graded severity in knock-in mutant mice

The GDF3-ALK7 signaling axis in adipose tissue: a possible therapeutic target for obesity and associated diabetes?

Activin E-ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice

Adipocyte Alk7 Links Nutrient Overload to Catecholamine Resistance in Obesity

Regulation of Metabolic Homeostasis by the TGF‐β Superfamily Receptor ALK7

A Val227Ala Substitution in the Peroxisome Proliferator Activated Receptor Alpha (PPAR Alpha) Gene Associated with Non‐alcoholic Fatty Liver Disease and Decreased Waist Circumference and Waist‐to‐hip Ratio

Mouse models for V103I and I251L gain of function variants of the human MC4R display reduced adiposity and are not protected from a hypercaloric diet

functional profiling and structural characterisation of the human A316T variant

The rs1421085 variant within FTO promotes brown fat thermogenesis

A common East-Asian ALDH2 mutation causes metabolic disorders and the therapeutic effect of ALDH2 activators

Combining evidence from human genetic and functional screens to identify pathways altering obesity and fat distribution

Reversal of obesity development in Ceacam1-/- male mice by bone marrow transplantation or introduction of the human CEACAM1 gene

Abstract 18237: Inhibition of Adenylyl Cyclase Type 5 Protects Against Obesity and Diabetes

Human Genetic Variation at rs10071329 Correlates with Adiposity-related Traits, Modulates PPARGC1B Expression, and Alters Brown Adipocyte Function

Visceral Adipose Tissue-directed Human Kallistatin Gene Therapy Improves Adipose Tissue Remodeling and Metabolic Health in Obese Mice

1671-P: T Cell Deficiency of STAT1 Reduces Obesity in Mice with High-Fat Diet or Aging

Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity

Identification of Rare Loss-of-Function Genetic Variation Regulating Body Fat Distribution

Ciliary localization of GPR75 promotes fat accumulation in mice

Effects of Obesity Related Genetic Variations on Visceral and Subcutaneous Fat Distribution in a Chinese Population

Inducible Loss of the Aryl Hydrocarbon Receptor Activates Perigonadal White Fat Respiration and Brown Fat Thermogenesis via Fibroblast Growth Factor 21